U.K. Dx firm launches massive glucose test strip recall; Do surgeons perform too many heart stent angioplasties?;

@FierceMedDev: UPDATED: Bard ordered to pay $2M in vaginal mesh trial defeat. News | Follow @FierceMedDev

@DamianFierce: A global cybersecurity outfit is lending a hand to the medical device industry. Article | Follow @DamianFierce

@MarkHFierce: Heathrow Airport have been warned that female terrorists might strike with breast implant explosives. Report | Follow @MarkHFierce

@MichaelGFierce: ICYMI: St. Jude nets FDA approval for low-radiation ablation catheters. Article | Follow @MichaelGFierce

> Menarini Diagnostics is recalling more than 1.7 million of its GlucoMen LX Sensor blood glucose test strips in the U.K., warning of inaccurate test results. Article

> Cardica ($CRDC) has filed for FDA clearance for its MicroCutter Xchange cutting and stapling device. News

> San Diego's Genalyte has launched a Type 1 diabetes assay that measures 7 autoantibodies associated with the destruction of pancreatic islet cells. Release

> The in vitro diagnostics market will reach $1.1 billion by 2018, Transparency Market Research concludes in a new report. Item

> Ortho Kinematics gained 510(k) clearance to expand the use of its vertebral motion diagnostic device to neck assessments, beyond the lumbar spine. Item

> Heart stent angioplasties are among the 5 most overused medical procedures, two major groups have concluded. Blog (sub. req.)

Biotech News

@FierceBiotech: We're looking for the fiercest women in biotech for our 2013 report. Editor's note | Nomination form | Follow @FierceBiotech

@JohnCFierce: MannKind rewarded for positive Afrezza data with $40M financing. Report | Follow @JohnCFierce

@RyanMFierce: Scientists found a causal link between a tooth cavity bacterium and colon cancer in mice, potential drug target. More from TheScientist | Follow @RyanMFierce

@EmilyMFierce: SeattleBioMed wins $16M NIH grant for tuberculosis research. ICYMI yesterday from FierceBiotechResearch.com | Follow @EmilyMFierce

> Shkreli's biotech Retrophin zeroes in on $25M financing with 'major' pharma deal looming. Article

> Epizyme picks up FDA orphan nod for lead cancer drug as going public pays off. News

> Ophthotech eyes $85M IPO to fund PhIII for drug to prevent blindness. Report

Pharma News

@FiercePharma: Trending online: Which are pharma's top 4 innovators? Hint: It's not the big guys. More | Follow @FiercePharma

@EricPFierce: FDA wants help figuring out how to stop addicts from getting to the APIs in opioid painkillers. Story from FiercePharmaManufacturing.com | Follow @EricPFierce

@CarlyHFierce: The latest in India vs. Big Pharma IP developments: Roche won't pursue Herceptin patents in India. Article | Follow @CarlyHFierce

> NICE denies Pfizer lung cancer drug in final guidance. Report

> Stada quickly pulls off deal for OTC maker Thorton & Ross. Article

> Easing U.S. drug spending gives Sanofi, Novo room to raise insulin prices. Story